Literature DB >> 8156235

Anaerobic bacteremia in a cancer center.

L M Noriega1, P Van der Auwera, M Phan, D Daneau, F Meunier, J Gerain, M Aoun.   

Abstract

Seventy-five episodes of clinically relevant anaerobic bacterial bacteremia observed in cancer patients were reviewed. Gastrointestinal (22.7%), hematological (22.7%) and female genital tract (18.6%) cancers were the most common underlying malignant diseases. Among 84 strains of strict anaerobic bacteria recovered in the 75 patients, gram-negative rods were isolated in 49 patients (58.3%), gram-positive rods in 29 patients (34.5%) and gram-positive cocci in 6 patients (8%). Bacteroides spp. and Clostridium spp. were the most frequent pathogens (85.7%). Twenty-one episodes of bacteremia were polymicrobial, aerobic gram-positive cocci being the most frequently associated pathogens. When identified, the primary sites were the gastrointestinal tract (40%), the female genital tract (17.3%), skin and soft tissue (14.6%), the oropharynx (12%) and the lower respiratory tract (6.7%). The source remained unknown in 7 cases (9.3%). The overall survival (evaluated 10 days after the occurrence of bacteremia) was 82.5%. There was no difference in mortality between patients with monomicrobial and polymicrobial bacteremia. Pulmonary complications were more frequent in patients with fatal outcome in comparison to patients who survived. The mortality rate of the patients adequately treated was 10.3% compared to 41% for the patients not treated or treated inadequately (P = 0.016, chi 2).

Entities:  

Mesh:

Year:  1993        PMID: 8156235     DOI: 10.1007/bf00366044

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  19 in total

Review 1.  Recent developments in the understanding of the pathogenesis and treatment of anaerobic infections (2).

Authors:  B Styrt; S L Gorbach
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

2.  Bacteroides bacteremia. Experience in a hospital for neoplastic diseases.

Authors:  M F Kagnoff; D Armstrong; A Blevins
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

3.  Anaerobic bacterial bacteremia: 12-year experience in two military hospitals.

Authors:  I Brook
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

4.  Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms.

Authors:  E Bouza; M Reig; M Garcia de la Torre; M Rodríguez-Créixems; J Romero; E Cercenado; F Baquero
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

5.  Anaerobic bacteremia in a general hospital: retrospective five-year analysis.

Authors:  F Vazquez; F J Mendez; F Perez; M C Mendoza
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

6.  Clinical importance of "breakthrough" bacteremia.

Authors:  M P Weinstein; L B Reller
Journal:  Am J Med       Date:  1984-02       Impact factor: 4.965

7.  Clostridial septicemia complicating the course of leukemia.

Authors:  J G Caya; S G Farmer; P S Ritch; N J Wollenberg; T M Tieu; H W Oechler; M Spivey
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

Review 8.  Polymicrobial bacteremia: clinical and microbiologic patterns.

Authors:  A G Reuben; D M Musher; R J Hamill; I Broucke
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

9.  Moxalactam treatment of anaerobic infections in cancer patients.

Authors:  H Lagast; F Meunier-Carpentier; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

10.  Bacteremia due to Bacteroidacceae: a review of 92 cases.

Authors:  R G Mathias; G K Harding; M J Gurwith; H G Stiver; E Sigurdson; C A Gratton; A R Ronald
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  3 in total

1.  Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.

Authors:  E Urbán
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

2.  Febrile neutropenia and Fusobacterium bacteremia: clinical experience with 13 cases.

Authors:  P Fanourgiakis; M Vekemans; A Georgala; D Daneau; A Vandermies; P Grenier; M Aoun
Journal:  Support Care Cancer       Date:  2003-03-13       Impact factor: 3.603

3.  The Performance of the Four Anaerobic Blood Culture Bottles BacT/ALERT-FN, -FN Plus, BACTEC-Plus and -Lytic in Detection of Anaerobic Bacteria and Identification by Direct MALDI-TOF MS.

Authors:  Mohammed Almuhayawi; Osman Altun; Adam Dilshad Abdulmajeed; Måns Ullberg; Volkan Özenci
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.